JP4218842B2 - 疲労度評価方法およびその利用 - Google Patents

疲労度評価方法およびその利用 Download PDF

Info

Publication number
JP4218842B2
JP4218842B2 JP2006529099A JP2006529099A JP4218842B2 JP 4218842 B2 JP4218842 B2 JP 4218842B2 JP 2006529099 A JP2006529099 A JP 2006529099A JP 2006529099 A JP2006529099 A JP 2006529099A JP 4218842 B2 JP4218842 B2 JP 4218842B2
Authority
JP
Japan
Prior art keywords
fatigue
substance
amount
human herpesvirus
candidate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006529099A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2006006634A1 (ja
Inventor
一博 近藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virus Ikagaku Kenkyusho Inc
Original Assignee
Virus Ikagaku Kenkyusho Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virus Ikagaku Kenkyusho Inc filed Critical Virus Ikagaku Kenkyusho Inc
Publication of JPWO2006006634A1 publication Critical patent/JPWO2006006634A1/ja
Application granted granted Critical
Publication of JP4218842B2 publication Critical patent/JP4218842B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/306—Chronic fatigue syndrome

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Educational Technology (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
JP2006529099A 2004-07-14 2005-07-13 疲労度評価方法およびその利用 Expired - Fee Related JP4218842B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004235667 2004-07-14
JP2004235667 2004-07-14
PCT/JP2005/012962 WO2006006634A1 (ja) 2004-07-14 2005-07-13 疲労度評価方法およびその利用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007188969A Division JP4812708B2 (ja) 2004-07-14 2007-07-20 疲労度評価方法およびその利用

Publications (2)

Publication Number Publication Date
JPWO2006006634A1 JPWO2006006634A1 (ja) 2008-05-01
JP4218842B2 true JP4218842B2 (ja) 2009-02-04

Family

ID=35783971

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006529099A Expired - Fee Related JP4218842B2 (ja) 2004-07-14 2005-07-13 疲労度評価方法およびその利用
JP2011129778A Expired - Lifetime JP5542093B2 (ja) 2004-07-14 2011-06-10 疲労度評価方法およびその利用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011129778A Expired - Lifetime JP5542093B2 (ja) 2004-07-14 2011-06-10 疲労度評価方法およびその利用

Country Status (3)

Country Link
US (3) US7824888B2 (enExample)
JP (2) JP4218842B2 (enExample)
WO (1) WO2006006634A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10067142B2 (en) 2014-06-27 2018-09-04 Japan Tobacco Inc. Method for diagnosing, treating, or preventing mood disorder
US10487118B2 (en) 2007-09-27 2019-11-26 Virus Ikagaku Kenkyusho Inc. Factor involved in latent infection with herpes virus, and use thereof
US10539578B2 (en) 2015-12-28 2020-01-21 Japan Tobacco Inc. Method for diagnosing, treating, or preventing mood disorders

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7824888B2 (en) 2004-07-14 2010-11-02 Virus Ikagaku Kenkyusho Inc. Methods for assessing fatigue level and applications thereof
US8672843B2 (en) * 2006-11-27 2014-03-18 Qtc Management, Inc. Automated protocol for determining psychiatric disability
CA2722952A1 (en) * 2008-03-31 2009-10-08 Japan Tobacco Inc. Quantitation method of virus
US9657324B1 (en) 2008-10-03 2017-05-23 Virus Ikagaku Kenkyusho Inc. Method for treating or preventing mood disorders
US20110313306A1 (en) * 2010-06-16 2011-12-22 Sociedad Europea de Analisis Diferencial de Movilidad Method and apparatus for monitoring stress levels or sudden changes of humor in humans or other individuals in real time by means of vapor analysis
US8812428B2 (en) 2010-09-20 2014-08-19 Pulsar Informatics, Inc. Systems and methods for assessment of fatigue-related contextual performance using historical incident data
US9030294B2 (en) 2010-09-20 2015-05-12 Pulsar Informatics, Inc. Systems and methods for collecting biometrically verified actigraphy data
US8568330B2 (en) 2011-03-08 2013-10-29 Pulsaw Informatics, Inc. Composite human physiological stress index based on heart beat and sleep and/or activity history data including actigraphy
US9002671B2 (en) 2011-04-29 2015-04-07 Pulsar Informatics, Inc. Systems and methods for latency and measurement uncertainty management in stimulus-response tests
NZ630770A (en) * 2013-10-09 2016-03-31 Resmed Sensor Technologies Ltd Fatigue monitoring and management system
US12013365B2 (en) 2018-07-19 2024-06-18 Osaka University Virus measuring method, virus measuring device, virus determining program,stress determining method, and stress determining device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756281A (en) * 1991-05-23 1998-05-26 Martin; William John Stealth virus detection in the chronic fatigue syndrome
JPH1138004A (ja) 1997-07-16 1999-02-12 Pola Chem Ind Inc ストレスの定量法
JPH11304793A (ja) 1998-04-27 1999-11-05 Taisho Pharmaceut Co Ltd 抗精神疲労活性物質の評価方法
JP4123565B2 (ja) 1998-04-27 2008-07-23 大正製薬株式会社 抗精神疲労活性物質の評価方法
US7824888B2 (en) * 2004-07-14 2010-11-02 Virus Ikagaku Kenkyusho Inc. Methods for assessing fatigue level and applications thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10487118B2 (en) 2007-09-27 2019-11-26 Virus Ikagaku Kenkyusho Inc. Factor involved in latent infection with herpes virus, and use thereof
US10067142B2 (en) 2014-06-27 2018-09-04 Japan Tobacco Inc. Method for diagnosing, treating, or preventing mood disorder
US10539578B2 (en) 2015-12-28 2020-01-21 Japan Tobacco Inc. Method for diagnosing, treating, or preventing mood disorders

Also Published As

Publication number Publication date
US20110020789A1 (en) 2011-01-27
US20080280283A1 (en) 2008-11-13
JP5542093B2 (ja) 2014-07-09
JP2011177194A (ja) 2011-09-15
US20160068918A1 (en) 2016-03-10
JPWO2006006634A1 (ja) 2008-05-01
WO2006006634A1 (ja) 2006-01-19
US7824888B2 (en) 2010-11-02

Similar Documents

Publication Publication Date Title
JP5542093B2 (ja) 疲労度評価方法およびその利用
Evans et al. Neurologic complications associated with novel influenza A (H1N1) virus infection in children--Dallas, Texas, May 2009.
Kim et al. A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation
Gehlhar et al. Impaired virus‐induced interferon‐α2 release in adult asthmatic patients
Bosco et al. Decreased activation of inflammatory networks during acute asthma exacerbations is associated with chronic airflow obstruction
JP4812708B2 (ja) 疲労度評価方法およびその利用
Majeed et al. Epidemiological study in women infected with toxoplasma gondii, rubella virus, and cytomegalo virus in Al-Najaf Governorate-Iraq
Ashwlayan et al. Insight into the biological impact of COVID-19 and its vaccines on human health
Minjolle et al. Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings
Shen et al. Acute flaccid paralysis as the initial manifestation of Japanese encephalitis: a case report
Lee et al. Evaluation of a rapid diagnostic test, NanoSign® Influenza A/B Antigen, for detection of the 2009 pandemic influenza A/H1N1 viruses
AU2002360519B2 (en) Methods and compositions for the diagnosis of asthma
JP7033113B2 (ja) 疲労に関与する因子及びその利用
Goyal et al. Role of serum ferritin as a predictor of dengue severity: a prospective observational study from India
Pessoa-Gonçalves et al. Progressive multifocal leukoencephalopathy triggered by COVID-19 in a previously asymptomatic person living with undiagnosed HIV infection
WO2022232446A1 (en) Methods for assessing infection using mitochondrial cell-free dna
Borde et al. TBE in adults
JP2009031280A (ja) 疲労度評価方法およびその利用
Hessein et al. Helicobacter pylori inversely related to clinical and functional severity of adult asthma
RU2706126C1 (ru) Способ диагностики активности сочетанной инфекции у детей с острыми респираторными инфекциями
Anderson et al. 1409. Genomic Variation Among Respiratory Syncytial Viruses
Heymann et al. Virus-induced wheezing in children: respiratory syncytial virus (RSV) and rhinovirus
Padma et al. A Case Report of Meningitis Retention Syndrome.
Xie et al. Relationship between mental illness and negative nucleic acid conversion in patients with COVID-19
JP2007192659A (ja) 疲労度評価方法およびその利用

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080415

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080730

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081105

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081106

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111121

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4218842

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111121

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121121

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121121

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131121

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees